CLINICAL_TRIALS
trial_result
· 2018-10-18
Clinical Trial Update: A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart [Phase 1]
Summary
Phase 1 study evaluating the effects of LY2409021 on cardiac electrical impulses in adults with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-10-18